UK to boost clinical trial participation

The UK government will take steps to make sure patients are better informed of opportunities to participate in clinical trials, according to the country's health minister. Doctors in the UK "already have a duty to advise patients, in each patient's best interest, about all aspects of their treatment, including research," a UK Department of Health spokesperson told __The Scientist__ in an Email. But UK Secretary of State for Health linkurl:Alan Johnson,;http://www.number-10.gov.uk/output/Page630

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The UK government will take steps to make sure patients are better informed of opportunities to participate in clinical trials, according to the country's health minister. Doctors in the UK "already have a duty to advise patients, in each patient's best interest, about all aspects of their treatment, including research," a UK Department of Health spokesperson told __The Scientist__ in an Email. But UK Secretary of State for Health linkurl:Alan Johnson,;http://www.number-10.gov.uk/output/Page6309.asp said that the duty will be clearly laid out in a soon-to-be-released constitution for the country's health service. In a speech he gave yesterday (Jun 24), commemorating the 60th anniversary of the United Kingdom's National Health Service (NHS), Johnson outlined plans to make sure patients are told of studies relevant to them and to and make sure information is shared between pharmaceutical companies, academic institutions and other research centers. "I want every patient in the NHS to have the right to take part in approved medical research that is appropriate for them, if they choose to," Johnson said at the summit, linkurl:according;http://nds.coi.gov.uk/Content/Detail.asp?ReleaseID=371664&NewsAreaID=2 to the UK Department of Health. "And to underline the paramount importance of research, we will set out in the forthcoming NHS constitution the core role that it plays at the heart of the NHS." The NHS constitution will be unveiled this Monday (Jun 30) in the House of Commons, where Parliament will review the document before it's publically released, according to the Email. The Department of Health spokesperson also wrote that the guideline to better inform British patients of clinical trials "will not be a formal rule" in the constitution. "We shall make it easier to use care records confidentially where necessary so that the NHS can identify patients who are suitable for a particular approved study; and then discuss it with them so that they can choose whether to take part." Concurrent with Johnson's speech, the NHS released a linkurl:report;http://www.nihr.ac.uk/files/pdfs/60%20years%20of%20research%20in%20the%20NHS%20benefiting%20patients%20final.pdf yesterday outlining the agency's pledge to enliven clinical trial participation. The report cites an almost $7 billion (USD) yearly pharmaceutical industry contribution to research and development in the UK - 40 percent of which goes towards clinical trials - and underscores the importance of collaboration between universities, government agencies, and pharma and biotech companies. It mentions the linkurl:UK Centre for Medical Research and Innovation;http://www.the-scientist.com/blog/display/53962/ as a prime example of such a partnership.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo